The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


Sandoz head: Enbrel biosimilar Erelzi won't launch before 2018, delayed by legal battle

Patient requests buoy oral meds from Biogen, Novartis in crowded MS market

Supreme Court takes up Amgen, Sandoz's market-defining biosimilars dispute